Repozytorium
Wyszukaj
Kolekcje
Inne
Synthesis and structural characterisation of copper(II) 15-metallacrown-5 complexes with PbII, HgII, AgI, NaI and YIII central metal ions.
Autorzy
Rok wydania
2007
Czasopismo
European Journal of Inorganic Chemistry
Strony
3015-3022
DOI
10.1002/ejic.200600881
Kolekcja
Język
Angielski
Typ publikacji
Artykuł
The new copper(II) 15-metallacrown-5 complexes with the central metal ions PbII, HgII, AgI, NaI and YIII, with the formula [MCu5L5]Xn {H2L is 2-picolinehydroxamic acid or (S)-phenylalaninehydroxamic acid and X– is NO3– or Cl–}, have been synthesised and characterised by NMR and UV/Vis spectroscopy, electrospray mass spectrometry and elemental analysis. The PbII- and HgII 15-metallacrown-5 complexes were obtained in the crystalline form as pyridine adducts [PbCu5(picha)5(py)6](NO3)2·3(py) and [HgCu5(picha)5(py)7](NO3)2·2(py) and their X-ray crystal structures were determined. In both complexes, each peripheral CuII ion of the metallacrown is coordinated by one pyridine molecule bonded in the axial position. In the case of the PbII derivative, one additional axial pyridine molecule is bound to the central metal ion, while in the case of the HgII derivative, two axial pyridine ligands are bound to the central HgII ion. The relative stability of the copper(II) 15-metallacrown-5 complexes with various central metal ions was determined on the basis of competition reactions. The relative preference of the 15-metallacrown-5 system for the central metal ion follows the series NaI, AgI < lanthanide(III), HgII < PbII.
Adres publiczny
https://doi.org/10.1002/ejic.200600881
Strona internetowa wydawcy
Podobne publikacje
Synthesis and molecular structures of CuII 15-metallacrown-5 complexes with encapsulated CaII, PrIII and NdIII ions.
Safyanova Inna S., Golenya Irina A., Pavlenko Vadim A., Gumienna-Kontecka Elżbieta, Pekhnyo Vasily I., Bon Volodymyr V., Fritsky Igor O.
Synthesis and magnetic property of copper(II)–lanthanide(III) complexes [{CuIILLnIII(o-van)(CH3COO)(MeOH)}2]·2H2O(LnIII=GdIII, TbIII, and DyIII; H3L= 1-(2-hydroxybenzamido)-2-(2-hydroxy-3-methoxybenzylideneamino)ethane;o-van= 3-methoxysalicylaldehydato.
Hamamatsu T., Yabe K., Towatari Masaaki, Matsumoto Naohide, Re Nazzareno, Pochaba Andrzej, Mroziński Jerzy
Exploring the reactions of β-amyloid (Aβ) peptide 1-28 with AlIII and FeIII ions.
Valensin Daniela, Migliorini Caterina, Valensin Gianni, Gaggelli Elena, La Penna G., Kozłowski Henryk, Gabbiani C., Messori L.